Introduction
Welcome to PPI Healthcare Consulting
PPi HC Ltd is a pharmaceutical pricing, reimbursement (P&R) and market access specialist comprising an international network of country-based experts, each intimate with their respective healthcare systems and very familiar with commercialisation issues for pharmaceutical products. Pricing and reimbursement processes differ from country to country. PPi HC members are based in many global markets, have extensive knowledge and experience regarding their local market. PPi HC partners all have 20+ years’ experience.
The strength of PPi HC relies not just in the expertise in individual country markets but stands particularly in our combined expertise integrating the local differences into a common understanding and providing overall strategies. Thus we create special value for our clients. We at PPi HC have a solid track record of working together as a team and providing consulting services in over 400 assignments since 2002. We have experience in a broad range of healthcare industries and for all therapeutic areas. Our solid education in science and medicine as well as our background in clinical research/regulatory affairs/pharmacoeconomics/market research enables us to tackle the most difficult and complex challenges. We have performed projects in many countries across the world and have often been called to provide a 2nd opinion or final advice to a client.
Every case is unique and requires a tailor-made solution based on an in-depth knowledge of the systems specific to the country and the product concerned. Our strategies are designed to cater for the growth needs of our clients.
Locally Rooted and Common Process
Market Access as well as pricing and reimbursement are different from country to country. Therefore we are locally rooted and each partner has extensive knowledge about his country. We have a solid track record of integrating these local peculiarities into a common large picture for our clients.
Expertise
Market Access as well as pricing and reimbursement are different from country to country. Therefore we are locally rooted and each partner has extensive knowledge about his country. We have a solid track record of integrating these local peculiarities into a common large picture for our clients.
We have the expertise and experience in a broad range of therapeutic areas and healthcare industries to help our clients providing the relevant regulatory and marketing information and advice to successfully setup their best possible strategy to launch their products and assist them through the reimbursement process. As a result, our expertise in relation to pricing strategies can help clients to ensure the optimum return for their investment. The strength of PPi HC relies not just in the expertise in individual country markets but stands particularly in the combined expertise of reliable partners.
About
TESTIMONIALS
“With their depth of market access experience across the EU, Adam Barak and his team at PPi Healthcare are well-positioned to provide timely, insightful guidance on pricing and reimbursement. ProMetic’s global strategic launch plans involving ultra-orphan therapies, have been greatly enhanced by our collaboration with PPi.”
Kristine Dorward, Director, Marketing & Business Development, ProMetic Life Sciences Inc.
“I want to let you know that the feedback from my colleagues after your presentation was that they are impressed by the amount of information that you have gathered within the research within such a short period.”
Ramona Schmid, Global Market Access, Pricing and Reimbursement Manager, HRA Pharma
“I have worked with PPi on several projects and I will work with them again. The first project was a European pricing study for an orphan product. Having already completed one study with a competitor, I found the PPi team to be particularly insightful, having taken the time to completely understand this complex project.”
Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals
“Recently I completed an assessment to inform the collection of pharmacoeconomic data in a clinical study in the US and Europe. The team again were very insightful and we had unexpected value-added when we found a member of the PPi had been involved in the pricing and reimbursement activities relating to one of our comparables. Great team, great results!”
Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals
